ProKidney shares are trading sharply higher Wednesday morning. The stock is gaining following a marked surge on Tuesday driven by positive clinical trial data for its CKD treatment.
ProKidney shares are trading sharply higher Wednesday morning. The stock is gaining following a marked surge on Tuesday driven by positive clinical trial data for its CKD treatment.
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why
Talk about picking an awkward time to take a day off, eh? Wall Street was left licking its wounds yesterday after the hotter-than-expected US inflation
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why
A suspected Chinese spy and Singaporean chip deal reveal the Asian networks testing Washington’s grip on AI technology
As the Claude maker prepares to make its Wall Street debut, the FT’s interactive valuation calculator can help readers decide whether the AI giant is
Copyright © Louis Velazquez. All Rights Reserved.